Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Return on Assets (2024 - 2025)

Historic Return on Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.44%.

  • Tonix Pharmaceuticals Holding's Return on Assets rose 12700.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 12700.0%. This contributed to the annual value of 0.86% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Return on Assets is 0.44%, which was up 12700.0% from 0.43% recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Return on Assets' 5-year high stood at 0.38% during Q4 2023, with a 5-year trough of 1.72% in Q3 2024.
  • Moreover, its 3-year median value for Return on Assets was 0.63% (2024), whereas its average is 0.85%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -6900bps in 2024, then skyrocketed by 12700bps in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Return on Assets (Quarter) stood at 0.38% in 2023, then crashed by -182bps to 1.06% in 2024, then surged by 58bps to 0.44% in 2025.
  • Its Return on Assets was 0.44% in Q3 2025, compared to 0.43% in Q2 2025 and 0.74% in Q1 2025.